Michael A. Recny
Chief Executive Officer at Calvert Holdings, Inc.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Russ C. McLauchlan | M | - |
Calvert Laboratories, Inc.
 Calvert Laboratories, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Novo Nordisk Fonden, Calvert Laboratories, Inc. is a company that provides preclinical research, testing, and laboratory services. The company is based in Cary, NC. The CEO of the company is Michael A. Recny. Calvert Laboratories was acquired by Altasciences Co., Inc. from Calvert Holdings, Inc. on May 05, 2021.
Calvert Holdings, Inc.
 Calvert Holdings, Inc. Pharmaceuticals: MajorHealth Technology Calvert Holdings, Inc. operates as a holding company which develops preclinical drugs through its subsidiaries including Calvert Labs, Calvert Research and Crescent Green Management Advisors. The firm focuses on servicing early stage drug development companies. The company was founded by Russ McLauchlan in 1996 and is headquartered in Cary, NC. | 28 years |
| Charles B. Spainhour | M | - |
Calvert Holdings, Inc.
Calvert Holdings, Inc. Pharmaceuticals: MajorHealth Technology Calvert Holdings, Inc. operates as a holding company which develops preclinical drugs through its subsidiaries including Calvert Labs, Calvert Research and Crescent Green Management Advisors. The firm focuses on servicing early stage drug development companies. The company was founded by Russ McLauchlan in 1996 and is headquartered in Cary, NC.
Calvert Laboratories, Inc.
Calvert Laboratories, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Novo Nordisk Fonden, Calvert Laboratories, Inc. is a company that provides preclinical research, testing, and laboratory services. The company is based in Cary, NC. The CEO of the company is Michael A. Recny. Calvert Laboratories was acquired by Altasciences Co., Inc. from Calvert Holdings, Inc. on May 05, 2021. | - |
| Anthony Yousefnejad | M | - |
Calvert Holdings, Inc.
Calvert Holdings, Inc. Pharmaceuticals: MajorHealth Technology Calvert Holdings, Inc. operates as a holding company which develops preclinical drugs through its subsidiaries including Calvert Labs, Calvert Research and Crescent Green Management Advisors. The firm focuses on servicing early stage drug development companies. The company was founded by Russ McLauchlan in 1996 and is headquartered in Cary, NC. | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Timothy J. Creech | M | 63 |
Trimeris, Inc.
 Trimeris, Inc. Pharmaceuticals: MajorHealth Technology Trimeris, Inc. develops therapeutics for viral diseases. It is a biopharmaceutical company engaged in the discovery, development and commercialization of novel therapeutic agents for the treatment of viral disease. The core technology platform of fusion inhibition is based on blocking viral entry into host cells. The company was founded in 1993 and is headquartered in Durham, NC. | 7 years |
| Andrew L. Graham | M | - |
Trimeris, Inc.
Trimeris, Inc. Pharmaceuticals: MajorHealth Technology Trimeris, Inc. develops therapeutics for viral diseases. It is a biopharmaceutical company engaged in the discovery, development and commercialization of novel therapeutic agents for the treatment of viral disease. The core technology platform of fusion inhibition is based on blocking viral entry into host cells. The company was founded in 1993 and is headquartered in Durham, NC. | 7 years |
| Steve Graves | M | - |
Rochester Christian University
| 3 years |
| M. Ross Johnson | M | 79 |
Trimeris, Inc.
Trimeris, Inc. Pharmaceuticals: MajorHealth Technology Trimeris, Inc. develops therapeutics for viral diseases. It is a biopharmaceutical company engaged in the discovery, development and commercialization of novel therapeutic agents for the treatment of viral disease. The core technology platform of fusion inhibition is based on blocking viral entry into host cells. The company was founded in 1993 and is headquartered in Durham, NC. | 4 years |
| Jonathan Lemco | M | - |
Rochester Christian University
| 5 years |
| Sumantri Slamet | M | 70 |
University of Illinois
| 3 years |
| Tim Tighe | M | - |
Rochester Christian University
| 5 years |
| Ronald H. Fielding | M | - |
Rochester Christian University
| 6 years |
| Lawrence D. Levin | M | - |
University of Illinois
| 8 years |
| Jy-ber Lee | M | 69 |
University of Illinois
| 5 years |
| Hugh A. Abrams | M | - |
University of Illinois
| 6 years |
| Mark S. Albert | M | - |
University of Illinois
| 4 years |
| Haris Basit | M | 63 |
University of Illinois
| 6 years |
| Gregory Kazarian | M | 61 |
University of Illinois
| 8 years |
| Rick Bailer | M | - |
Rochester Christian University
| 5 years |
| Brian T. Schinderle | M | - |
University of Illinois
| 4 years |
| Daniel R. Kastholm | M | - |
University of Illinois
| 6 years |
| Mark Wdowik | M | - |
University of Illinois
| 5 years |
| Kenneth M. Lies | M | - |
University of Illinois
| 6 years |
| Jim E. Quinn | M | - |
University of Illinois
| 6 years |
| Joe Geagea | M | 64 |
University of Illinois
| 5 years |
| Rick George | M | - |
University of Illinois
| 9 years |
| Wei Long Lee | M | 76 |
University of Illinois
| 3 years |
| Jerry Stevens | M | - |
University of Illinois
| 4 years |
| Ho-Yeong Kim | M | 75 |
University of Illinois
| 3 years |
| F. Javier Cevallos | M | - |
University of Illinois
| 7 years |
| Mitch Kovitz | M | - |
University of Illinois
| 5 years |
| Jason S. Steigman | M | - |
University of Illinois
| 5 years |
| Richard A. Franco | M | 82 |
Trimeris, Inc.
Trimeris, Inc. Pharmaceuticals: MajorHealth Technology Trimeris, Inc. develops therapeutics for viral diseases. It is a biopharmaceutical company engaged in the discovery, development and commercialization of novel therapeutic agents for the treatment of viral disease. The core technology platform of fusion inhibition is based on blocking viral entry into host cells. The company was founded in 1993 and is headquartered in Durham, NC. | 3 years |
| Douglas E. Scott | M | 67 |
University of Illinois
| 6 years |
| Michael Caplan | M | - |
Rochester Christian University
| 7 years |
| Nardin L. Baker | M | - |
University of Illinois
| 6 years |
| Jeffrey A. Tischler | M | 68 |
Rochester Christian University
| 5 years |
| Michael Stuart Rosen | M | 63 |
Rochester Christian University
| 5 years |
| Richard F. Rashid | M | - |
Rochester Christian University
| 4 years |
| Larry Rakers | M | 61 |
University of Illinois
| 6 years |
| Orrin J. Edidin | M | 63 |
University of Illinois
| 7 years |
| Dani Paul Bolognesi | M | - |
Trimeris, Inc.
Trimeris, Inc. Pharmaceuticals: MajorHealth Technology Trimeris, Inc. develops therapeutics for viral diseases. It is a biopharmaceutical company engaged in the discovery, development and commercialization of novel therapeutic agents for the treatment of viral disease. The core technology platform of fusion inhibition is based on blocking viral entry into host cells. The company was founded in 1993 and is headquartered in Durham, NC. | 11 years |
| James Kang | M | 61 |
University of Illinois
| 4 years |
| Gregory A. O'Berry | M | 63 |
University of Illinois
| 4 years |
| Bob Kirby | M | - |
University of Illinois
| 5 years |
| Bob Gallup | M | - |
University of Illinois
| 4 years |
| Marc E. Bercoon | M | - |
University of Illinois
| 4 years |
| Robert William Foran | M | - |
University of Illinois
| 4 years |
| Rick Tauber | M | - |
University of Illinois
| 4 years |
| Joseph E. Kuchta | M | - |
University of Illinois
| 4 years |
| Brent Myers | M | - |
University of Illinois
| 4 years |
| Michael Rowe | M | - |
University of Illinois
| 4 years |
| Christopher Domke | M | - |
University of Illinois
| 4 years |
| Douglas M. Ruschau | M | 65 |
University of Illinois
| 4 years |
| Scott W. Wilton | M | 63 |
University of Illinois
| 4 years |
| Shirley Sadjadi Sotomayor | F | - |
University of Illinois
| 4 years |
| Shi-Yi Liu | M | - |
University of Illinois
| 4 years |
| Olusegun Salako | M | - |
University of Illinois
| 3 years |
| James D. Wareham | M | - |
University of Illinois
| 4 years |
| Tom Kiley | M | - |
University of Illinois
| 4 years |
| Mark Peterson | M | 60 |
University of Illinois
| 4 years |
| Michael W. Bell | M | 60 |
University of Illinois
| 4 years |
| Bruce Hedgcock | M | - |
University of Illinois
| 4 years |
| Patrick Burke | M | - |
University of Illinois
| 4 years |
| Rita M. Rodriguez | M | 81 |
University of Illinois
| 4 years |
| Karin O’Connor | F | - |
University of Illinois
| 4 years |
| Leonid Sagalovsky | M | - |
University of Illinois
| 6 years |
| David Scott Richter | M | 63 |
University of Illinois
| 4 years |
| Jeffrey Margolis | M | 60 |
University of Illinois
| 4 years |
| Dennis C. Wilke | M | - |
University of Illinois
| 4 years |
| Annette Marie Bechtold | F | - |
University of Illinois
| 4 years |
| Thomas J. Connolly | M | 65 |
University of Illinois
| 4 years |
| Sue Cho | F | - |
University of Illinois
| 2 years |
| James Pieczynski | M | 61 |
University of Illinois
| 4 years |
| Edward S. Best | M | - |
University of Illinois
| 4 years |
| Faysal Sohail | M | 60 |
University of Illinois
| 4 years |
| Tom Dobrino | M | - |
University of Illinois
| 4 years |
| Michael V. Vivoda | M | 64 |
University of Illinois
| 4 years |
| Bruce A. Esworthy | M | - |
University of Illinois
| 4 years |
| Christopher Niemann | M | - |
University of Illinois
| 4 years |
| Thomas E. Bahn | M | - |
University of Illinois
| 4 years |
| Edward M. Ordonez | M | 62 |
University of Illinois
| 4 years |
| Franklin U. Valderrama | M | 62 |
University of Illinois
| 4 years |
| Lisa Aly | F | - |
University of Illinois
| 4 years |
| Mark S. Kopinski | M | - |
University of Illinois
| 2 years |
| Thomas E. Pabst | M | 65 |
University of Illinois
| 4 years |
| Rene L. Cruz | M | - |
University of Illinois
| 4 years |
| Sandra Lee Henjum | F | 62 |
University of Illinois
| 1 years |
| Michael Joseph Reilly | M | - |
University of Illinois
| 4 years |
| Jeffrey R. Patt | M | - |
University of Illinois
| 4 years |
| Kent Frederick Schien | M | - |
University of Illinois
| 4 years |
| James Johnson | M | 64 |
University of Illinois
| 4 years |
| Kurt J. Roemer | M | - |
University of Illinois
| 4 years |
| Woody Sing-Wood Yeh | M | - |
University of Illinois
| 3 years |
| John Mass | M | 58 |
University of Illinois
| 4 years |
| Gregory A. Paw | M | - |
University of Illinois
| 4 years |
| Larry Kaplan | M | - |
University of Illinois
| 4 years |
| Michael S. Polacek | M | 60 |
University of Illinois
| 4 years |
| Paul Pittman | M | 61 |
University of Illinois
| 5 years |
| Neil Reisman | M | 62 |
University of Illinois
| 4 years |
| Michael W. Reschke | M | 68 |
University of Illinois
| 3 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Michael A. Recny
- Personal Network
